1811 Expression levels of ERBB2, ESR1, immune and proliferation signatures measured by RNASeq predict response to anti-HER2 treatment in the neoALTTO trial. (September 2015)
- Record Type:
- Journal Article
- Title:
- 1811 Expression levels of ERBB2, ESR1, immune and proliferation signatures measured by RNASeq predict response to anti-HER2 treatment in the neoALTTO trial. (September 2015)
- Main Title:
- 1811 Expression levels of ERBB2, ESR1, immune and proliferation signatures measured by RNASeq predict response to anti-HER2 treatment in the neoALTTO trial
- Authors:
- Sotiriou, C.
Venet, D.
Fumagalli, D.
Maetens, M.
Rothé, F.
Ignatiadis, M.
Bradbury, I.
Harbeck, N.
Gomez, H.
Chang, T.W.
Coccia-Portugal, M.A.
Di Cosimo, S.
De Azambuja, E.
De la Pena, L.
Nuciforo, P.
Armour, A.
Eidtmann, H.
Baselga, J.
Piccart, M.
Loi, S. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 51:(2015)Supplement 3
- Journal:
- European journal of cancer
- Issue:
- Volume 51:(2015)Supplement 3
- Issue Display:
- Volume 51, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 51
- Issue:
- 3
- Issue Sort Value:
- 2015-0051-0003-0000
- Page Start:
- S269
- Page End:
- Publication Date:
- 2015-09
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(16)30764-X ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2029.xml